JnJ recalls surgical staplers due to potential failure; USFDA terms it as severest
JnJ Ethicon unit confirmed serious injuries to two patients, related to the use of the recalled product, the FDA said.
U.S: The U.S. Food and Drug Administration warned of risks of serious injury or death from surgical staplers made by Johnson & Johnson's (JnJ) Ethicon unit, labelling a recent recall of the device as its most serious.
The recall, initiated early April by Ethicon, covers 92,496 surgical staplers and is now labelled as "Class-1" - the strictest form of recall issued by FDA, where the use of faulty devices may cause serious injury or death.
J&J's Ethicon unit confirmed serious injuries to two patients, related to the use of the recalled product, the FDA said.
Read Also: CDSCO releases Risk classification of newly notified Medical Devices, IVDs; Details
The staplers, regulated as Class I medical devices that do not require a premarket submission to the FDA, are used by surgeons during gastrointestinal procedures.
The FDA will hold an advisory committee meeting on May 30 to discuss whether reclassifying the staplers for internal use as Class II medical devices would be appropriate.
The reclassification would subject the staplers to premarket notification and allow the FDA to establish further regulation on the device.
Read Also: CDSCO to hire 754 Regulatory Officers especially to regulate Medical Devices in country:DTAB
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd